Spontaneous resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Pediatric Blood and Cancer

Volumn 55, Issue 4, 2010, Pages 754-756

  Belyea, Brian ^a   Hinson, Ashley ^a   Moran, Cassandra ^a   Hwang, Eugene ^a   Heath, Jessica ^a   Barfield, Raymond ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus; Hemophagocytic lymphohistiocytosis; Pediatrics

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; FERRITIN; HEMOGLOBIN; INTERLEUKIN 2 RECEPTOR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTOSIS; HOSPITAL DISCHARGE; HUMAN; LEUKOCYTE COUNT; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; NEUTROPHIL COUNT; PANCYTOPENIA; PETECHIA; PRIORITY JOURNAL; REMISSION; SEROLOGY; SPLENOMEGALY; THROMBOCYTE;

ADOLESCENT; ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE;

EID: 77957050182     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22618     Document Type: Article

References (12)

1. Henter J-I, Horne AC, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
2. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665-2673.
3. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocyctic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869-1874.
4. Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007; 7: 814-822.
5. Henter J-I, Arico M, Egeler RM, et al. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997; 28: 342-347.
6. Henter J-I, Elinder G, Ost A, et al. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991; 18: 29-33.
7. HLH-2004 Treatment Protocol of the Second International HLH Study 2004.
8. Henter J-I, Samuelsson-Horne AC, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplant. Blood 2002; 100: 2367-2373.
9. Ouachée-Chardin M, Elie C, de Saint Basile G. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: A single-center report of 48 patients. Pediatrics 2006; 117: e743-e750.
10. Imashuku S, Teramura T, Tauchi H, et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004; 89: 183-188.
11. Thompson PA, Allen CE, Horton T, et al. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009; 52: 621-625.
12. RamaChandran S, Ariffin H. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009; 53: 488-490.